Middle Individual Division

Challenge 1
Though the Nanofirst emergency medicine system has issues, these issues are not as severe as influencers and neg-media make out. This could be a problem because false information about nanotechnology can be spread quickly across social media. This could change people’s opinions negatively about nanotechnology and also spread misinformation about how nanotechnology is used and its importance. The public is therefore unaware of the true purpose of nanotechnology and only sees the negative aspects of using it in medicine.

Challenge 2
The Nanofirst respirocytes would not deploy when treating a patient. This could be a problem because patients are not receiving the technology they need that could save their life in time. This may lead to an increase in deaths because the Nanofirst system does not treat all patients quickly enough in situations that mean life and death. It signifies the issues with coding and programming within the Nanofirst system which has a wider impact on many patients. It also shows the lack of power doctors have in deciding how to treat a patient and neglects the qualifications that they have gained.

Challenge 3
The future scene states that this isn’t the first time that two nanotechnology companies’ technology are incompatible. This might be a problem because collaboration is needed to make breakthroughs that could save lives. If companies do not work together, there would be an inefficient use of resources as big projects need large amounts of equipment and technology. Furthermore, this also means that less issues are resolved and there is no cross checking of patients and there physical and mental state.

Challenge 4
Dr Robbins wonders if corporations are just protecting their intellectual property and market share. Companies protecting their market share might be a problem because this shows that corporations care more about money and what they can exploit from consumers than the privacy of the consumers. This would increase the inequality between the rich people with access to advanced nanotechnology and the poorer people who cannot afford to use nanotechnology.

Challenge 5
In the future scene, it is stated that Nanofirst is not designed for long term function. This could be a problem because the Nanofirst technologies would have to be rebuilt constantly and are not sustainable. This might cause pollution to the environment, or the particles in the technology might be inhaled by humans which is bad for their physical health. The Nanofirst technologies could enter soil organisms and disrupting food chains and biodiversity because they are constantly being produced by large corporations.

Challenge 6
Xander questions why he can’t just do the jobs he has been trained to do. This could be a problem because it shows that the machines have a large control over the doctors and what surgeries they can perform on patients. When the machines overpower doctors, they might take over the medical field and patients would be treated without empathy or care as a result. The excess power the nanotechnology has might result in the technologies overtaking humans in the medical environment. The time and effort that doctors have put into gaining their qualifications would then be wasted.

Challenge 7
Ella notes that nanotechnology is no replacement for human experience and decision making, especially in complex environments. This could be a problem because it shows that nanotechnology is unable to make difficult moral decisions that impact a human’s life because they lack empathy. It also shows that nanotechnology is not developed enough to be able to control all aspects of medicine, even though it is already widely used in Queensland.

Challenge 8
Dr Robbins is upset because the virtual assistant has misunderstood which issues are the most important for human health and wellbeing. This might be a problem because the humans who are in need of the most help in a medical emergency might not be treated first. This might result in more deaths because the virtual assistant doesn’t have its priorities right. Less patients in serious situations can be treated this way and have access to the immediate healthcare that they need.

Underlying Problem
The future scene states that diagnostics are good but no replacement for human experience and decision making, especially in complex environments. How might we develop Nanofirst nanotechnology so that technology works collaboratively with doctors ensuring optimum treatment for patients in 2042 Queensland and beyond?

Solution 1
Nanofirst will create NanoHealth Networks, which connects doctors, biologists, and data engineers across Queensland through holographic interfaces monitored by medical nanobots. NanoHealth Networks keeps patient data safe by locking it in a system where only registered doctors can access it. When this data needs to be used, such as any special conditions or diseases, the NanoHealth Network will guide the doctor on what steps to take customised to a patient’s specific needs. This developed allows for patients to receive individual treatment with methods or medicines that doctors may have not considered using without the network.

Solution 2
Nanofirst nanotechnology will create NanoMind, which is a sensor system to predict the external system of a patient. Examples of the things that a sensor can detect is heart rate, sweat, bleeding, and if there are any broken bones. This information is relayed to the doctor in real time through an interconnected system for all the hospitals in the city. A doctor is then able to confirm if the patient’s situation is dire and which specialised hospital a patient should be delivered to to ensure progression and recovery. Developing this sensor allows for doctors to have control and judgement of the severity of medical emergencies.

Solution 3
NanoMind will have a sub group that creates nanodevices that analyses a patient’s blood sample. This nanodevice is able to enter the patient as it binds to haemoglobin in the patient and travels through the patient’s circulatory system without doing any harm to the organs. It is able to detect sugars on the coats of viruses or any harmful bacteria in the body. These nanodevices then destroy possible harmful substances in a patient's body by binding to the virus or bacteria. It then swallows the harmful substance in a similar process to phagocytosis. This eliminates diseases causing pain in a patient's body if a doctor is not able to come to the scene in time. This solution would help the patient receive adequate healthcare painlessly and reduce the strain and pressure on doctors throughout Queensland.

Solution 4
Nanofirst will create NanoNeural. This is a communication system between nanobots and doctors, where they are able to communicate through neural signals. Doctors was a Neural Input Patch which sits on the back of the wrist and sends bio electrical impulses and brainwave partners so the Nanofirst robot can detect micro decisions. Specific patterns of electrical signals signal the technology to focus on different parts of the patient. This allows the doctor to control the nanobot without being onsite and to control the order in which the patients are being treated. By communicating together, there is enhanced collaboration between doctors and technology.

Solution 5
The Nanofirst technology at the scene of the incident scans the scene and then replicates a holographic image of the scene in hospital systems. While doctors assess the level of severity of the accident and and organise what specialised doctors to help the patient, the nanomaterials provide primary care. Examples of primary care including giving water if there are burns or creating a holographic cast so that the patient does not feel any pain before the doctor reaches the scene. This development allows for the doctor to assess the situation and provide treatment while the nanomaterials act as an anaesthesiologist, reducing pain for the patient.

Solution 6
Nanofirst technology will develop NanoFeel alongside other doctors and recovered patients. Using simulated testing with nanotechnology and AI models on computers, the NanoFeel system will take note of things like human touch and the tone of a doctor’s voice when they talk to a patient. Through many rounds of testing, the Nanofirst technology replicates these behaviours and is able to provide more empathy towards the patient and make them feel more comfortable and safe. Patients describe their feels in real life situations and this system notes down all the actions that make patients comfortable. This reduces the gap between human empathy and technology. The Nanofirst technology evolves after its past patients and eventually realistically replicates human nature.

Solution 7
Nanofirst will develop a medical device called a NanoWatch. A NanoWatch is similar to an electronic watch and is worn on both a doctor and the Nanofirst technology. When a technology takes note of a life or death situation, such as an unusually high rate of bleeding or heart rate, it will trigger the alarm on the watch. A Nanosuit forms like a hologram on the doctor and it is transported to the destination of the patient immediately while the Nanofirst technology takes action to stop the bleeding or reduce unusual heart rate. The Nanosuit is powered through solar energy and hovers in the sky as well as containing emergency medical supplies. It transports the doctor to the patient faster.

Solution 8
Queensland will have an interconnected system to hospitals that have different purposes, such as for treating internal emergencies or for treating broken bones and torn muscles. Nanopods will be placed throughout the city and travel to a patient in the form of molecules when they are notified. These nanopods then join together with the oxygen molecules in the air to form a structure where a patient can lie on. It scans the patient and identifies which hospital the patient will be best treated in. These nanopods can also evaluate the background of a patient and assess why an accident happened. It then gives some insight to the doctor on how to treat the patient with the information it had recorded and its past experiences.

Criterion 1
Which solution is the best for developing Nanofirst nanotechnology?

Criterion 2
Which solution ensures the best collaboration between doctors and Nanofirst nanotechnology?

Criterion 3
Which solution is the most efficient treatment of patients in Queensland?

Criterion 4
Which solution will be the most cost effective way for medical professionals to provide Nanofirst nanotechnology to patients in Queensland?

Criterion 5
Which solution is the most environmentally friendly to the ecosystems and land within Queensland?

ALoU 1

Solution #:
4

Summary:
Neural communication system between doctors and nanobots

Advantages:
This solution is very good at ensuring collaboration between doctors and Nanofirst nanotechnology, fitting in with criterion 2. This is because the neural communication system allows for the Nanofirst technology to convey what is happening on the scene and specific symptoms on the scene. At the same time, the doctor communicates how to treat the patient and any specific steps that need to be undertaken. This solution is very effective for treatment of patients, beneficial for criterion 3 because patients are treated quickly through the robots while receiving the empathy and care that they would from a regular doctor with qualifications. This solution is somewhat cost effective, fitting with criterion 4 because no new technology needs to be built to have effective collaboration between doctors and robots. This solution is extremely beneficial towards criterion 5 because the manufacturing of chips is very small and does not have a large impact on the environment, reducing the pollution and excess technology that is dumped in the environment every year.


Limitations:
This solution may not benefit criterion 1 because it does not develop Nanofirst nanotechnology directly but instead just strengthens the bond between the doctor and the technology performing the treatment. This does not create an advancement in the actual machine and its ability to assess a patient’s situation or its understanding of human health and wellbeing. However, this can be improved by combining empathy simulations with the technology and past patients to improve its ability to care and create a comfortable environment. This makes the technology more advanced while giving control to the doctor. This solution is also only partially beneficial towards criterion 4 because while it does not need to be built on a large scale, it is expensive to be able to establish the neural connections in the air that occur between the doctor and the patient.


Unique Possibilities:
This solution can be combined with the solutions of increasing the empathy and the physical ability of the Nanofirst technologies. This means that before the connection is established between the doctor and the technology, the technology knows which treatments to apply on the patient to reduce the pain. The technology could also have built in sensors that analyse a patients blood flow, sweat, heart rate, and blood glucose concentration. This information is also relayed to the doctor through the neural connections and allows the doctor to have a more comprehensive understanding of the situation. This allows doctors to see patients on a more microscopic level and identify any damaged tissues earlier. The sensors can also scan images in detail of the patient with consent and the doctor is able to visually see any injuries that a patient has. By developing the machine itself and improving collaboration, nanotechnology is likely to be used in a more ethical and efficient way in the future.

ALoU 2

Solution #:
2

Summary:
Using sensors to assess a patient

Advantages:
This solution fits criterion 1 as it is a big step in developing useful Nanofirst nanotechnology. The Nanofirst system is enhanced because it is able to sense microscopic changes to a patient. This is essential in deciding how to treat the patient and their needs. The Nanofirst nanotechnology can be therefore expanded because it is detailed. This solution is somewhat efficient for treatment of patients, fitting criterion 3 because it provides a wide range of solutions of how to treat patients and provides reasons for a patient’s distress or the medical accident happening. This solution is very cost effective because sensors are small and do not cost a lot to apply on the Nanofirst nanotechnology. With more sensors, a more comprehensive image of the patient can be formed. This solution somewhat fits criterion 5 because sensors do not take up a lot of space in landfill and do not create carbon emissions.


Limitations:
The solution does not necessarily benefit criterion 2 because it does not have a very strong connection between collaboration between doctors and Nanofirst nanotechnology. However, it can provide doctors with more treatment ideas and can be combined with communication systems so that the doctor assesses all the solutions and guides the technology on what to do. This solution furthermore only supports criterion 3 to a small extent because it does not provide a solution for how a doctor can get to a patient in a small amount of time. While doctors have the information, there is no system connecting them to the patient. This solution might not be environmentally friendly because its sensors require energy to run and there needs to be a lot of sensors produced for each robot, creating waste.


Unique Possibilities:
Nanofirst nanotechnology can not only sense small changes to a patient but also provide a system listing all the different ways to cure a patient and possible benefits and negatives of each method. This creates more possibilities on the treatment of a patient and expands the healthcare field largely. Electrical signals can be transported to a doctor’s office or screen in real time that shows the changes in a patient, allowing the doctor to predict trends in how a patient is doing and suggest a treatment. Sensors can become solar powered, which is a renewable energy source and reduces the environmental impact of the sensors. The sensors that are used can also be sterilised so that they will not emit any toxic nanoparticles that enter a person's lungs or blood flow without them noticing. This creates a more healthy air within Queensland.

Action Plan
The best solution for developing effective collaboration between doctors and nanotechnology is the creation of NanoNeural, an advanced neural communication system by Nanofirst. NanoNeural allows doctors to communicate directly with nanobots through neural signals, using a Neural Input Patch on the back of the wrist. The neural data flows both ways and creates a shared field of awareness, where the doctor and technology perceive the patient’s condition together. This patch detects bioelectrical impulses and brainwave patterns linked to a doctor’s micro-decisions. Specific neural signals are translated into commands that direct nanobots to focus on certain areas of the patient’s body or adjust treatment intensity. Through this system, doctors can oversee and guide nanobot procedures remotely, ensuring that technology operates under human judgment and ethical decision-making, especially in complex medical environments.

The empathetic thoughts of the doctor and their care for a patient can be translated onto the Nanofirst technology which then uses a softer tone and softer hand movements. The nanobot is able to slow enzyme dispersal within a doctor if their thoughts and decisions become rushed or if their movements become tense. Through the chip, the technology gives the doctor advice and many solutions to the doctor on how the patient can be cured. The doctor takes in this advice and analyses which is the highest priority and most important for the patient. Through the nanobot, a doctor can also see a living hologram of how the nanobots are interacting with a patient and physically control the bot.

This plan will involve Nanofirst engineers, Queensland hospital specialists and doctors, and AI ethicists working collaboratively to design, test, and implement NanoNeural across major hospitals by 2042. Initially, trial simulations happen when a doctor is connected to a nanobot trying to treat a holographic patient. Over the next five years, NanoNeural will expand, allowing doctors in remote regions to control nanobot procedures through neural links. The nanobots will eventually develop so that they can determine the type of medical issue a patient is facing and which speicliased hospital to go to. Doctors will undergo specialised neural interface training to learn how to interpret feedback and maintain control of nanobot even when physically distant from patients.

Key sources of assistance will include the Queensland Department of Health and government, which will provide funding and access to clinical research facilities, and Nanofirst laboratories, which will manage software. There will also be online fundraising through social media and websites which promote NanoNeural and equal access to healthcare for all citizens. These online fundraising websites promote the importance of the collaboration of humans and doctors in medicine and give examples of how regular humans can contribute towards this cause. The students and teachers at the University of Queensland will offer expertise in neural interface design. AI ethics boards, the Queensland Department of Health and medical associations will ensure safe and regulated implementation. They will check all the Nanofirst chips in a scanning system to ensure that it does not cause any damage to internal organs or human health when inhaled. Patient advocacy groups will also provide feedback on comfort and consent to ensure ethical use of NanoNeural in public healthcare systems. This contributes largely towards the development of a more innovative system.

NanoNeural strongly meets the FPS criteria of 2, 3, 4, and 5 for collaboration, treatment of patients, cost effective and environmentally friendly. It enhances precision by detecting small changes in a patient while keeping human experience central, as doctors still interpret and control all critical actions. By fitting into criterion 2, this solution improves the connection between humans and machines, revolutionising medicine. As both patients and the efficiency of doctors benefit from this solution, it benefits the majority of people in Queensland and widens medical breakthroughs. The solution is realistic within 2042 technology projections, using plausible advances in neural mapping and remote nanobot communication. It also shows positive impact, ensuring equal access to advanced treatment for many communities, while maintaining the doctor’s role as the primary decision-maker in every medical situation. The maintenance and combination of ethical and moral thinking with highly detailed and specific data is beneficial for the patient’s health overall.

Possible obstacles include the ethical risks of reading and transmitting neural signals, potential technical malfunctions in communication between nanobots and human operators, and the high costs of early development. There may also be public mistrust of neural technology or concerns about data privacy. The misinformation and negative information about nanotechnology spread online could change the general public’s perceptions on nanotechnology and cause them to disencourage using it in healthcare. Additionally, environmental activists may not be supportive of the production of nanochips which may end up in landfill. Ethicists and human rights activists might also be concerned because using the nanosensor might still be a breach of privacy if they can track someone in higher detail. To overcome these, Nanofirst will establish strict medical privacy protocols and build transparent patient consent systems to ensure the privacy of patients. It will develop backup manual control modes to ensure safety in the event of signal interference or system errors, making the development of Nanofirst nanotechnology and the NanoNeural system morally correct. The nanosensors could also emit particles in the air which convert carbon dioxide into oxygen, purifying the air while having the dual purpose of improving a patient’s health.

NanoNeural directly addresses the Underlying Problem by ensuring that nanotechnology collaborates with, rather than replaces, doctors. It bridges human intuition and technological precision, allowing doctors to remain active decision-makers while nanobots perform microscopic tasks under their guidance and creating new possibilities for medical treatments. Through shared control and empath, NanoNeural creates a healthcare environment in which technology amplifies human capability. This ensures optimum, ethical, and compassionate treatment for all patients in 2042 Queensland and beyond.